News

Photo
07.12.2023 • News

AbbVie to Acquire Cerevel Therapeutics for $8.7 Billion

In a move to complement its neuroscience portfolio, US drugmaker AbbVie has agreed to acquire Cerevel Therapeutics, which has a pipeline of multiple clinical-stage and preclinical candidates with potential across several diseases including schizophrenia, Parkinson's disease (PD), and mood disorders.

Photo
06.12.2023 • News

Roche to Acquire Obesity Drug Maker Carmot

In a move to participate in the race for anti-obesity drugs, Swiss pharma giant Roche has agreed to acquire Carmot Therapeutics, a privately owned US company based in Berkeley, California.

Photo
05.12.2023 • News

Kemira Divests Oil and Gas Business to Sterling Specialty Chemicals

In a move to focus on its core businesses, Finnish chemicals company Kemira has signed an agreement to divest its oil and gas-related portfolio for €260 million to Sterling Specialty Chemicals, a US subsidiary of Artek Industries, a global industrial chemicals group based in India.

Photo
04.12.2023 • News

RoslinCT to Join Manufacturing Network for CRISPR-Based Therapy

UK’s RoslinCT, a cell and gene therapy contract development and manufacturing organization, will be part of the Vertex Pharmaceuticals global network producing the CRISPR-based therapy exa-cel, which will be used for treatment of sickle cell disease and transfusion-dependent beta thalassemia.

Photo
01.12.2023 • News

Arkema Closes Acquisition of 54% Stake in PI Advanced Materials

On Dec. 1, 2023, French chemicals and materials company Arkema has finalized the acquisition of Glenwood Private Equity’s 54% – based on a €728 million enterprise value – stake in South Korean company PI Advanced Materials (PIAM). Arkema said in a statement that this acquisition acquisition – first announced last June – complements its portfolio of high-performance technologies for the high-growth markets of advanced electronics and electric mobility.

Photo
01.12.2023 • News

AbbVie to Buy Cancer Drug Maker ImmunoGen for $10.1 Billion

US biopharma AbbVie has agreed to acquire ImmunoGen in a deal which values the company at about $10.1 billion and gives AbbVie access to flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved for platinum-resistant ovarian cancer (PROC), as well as a pipeline of promising next-generation ADCs.

Photo
01.12.2023 • News

Elementis Plans New R&D Unit in Portugal

UK’s Elementis, a global specialty chemicals company, will be opening a new unit in Portugal, featuring a center of excellence and R&D laboratory. The new unit, which will be headquartered in Porto and is scheduled to open in the first half of 2024, will support the company’s business segments Personal Care and Performance Specialties and also reinforce the current R&D capacity of the Elementis' laboratories in Asia and the Americas.

Photo
30.11.2023 • News

Borealis to Acquire Mechanical Recycler Integra Plastics

Olefins and polyolefins producer Borealis has signed an agreement to acquire Integra Plastics, a Bulgarian advanced mechanical recycling company. Closing of the transaction, for which no financial details were disclosed, is subject to customary regulatory approvals.

Photo
24.11.2023 • News

Novo Nordisk to Invest €2.1 Billion in French Production Site

Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production processes and an extension of the current Quality Control Laboratory.

Photo
22.11.2023 • News

TotalEnergies and SABIC Consider Selling US Chemical Plant

Major French oil company TotalEnergies SE and Saudi Basic Industries Corp. (SABIC) are considering selling a jumbo US plant that produces styrene and polystyrene, used in products such as plastic packaging, disposable cups, and insulation.

Photo
22.11.2023 • News

Merck & Co. to Acquire Caraway Therapeutics

Merck & Co. (MSD) and Caraway Therapeutics announced that the companies have agreed Merck & Co., through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to €557 million ($610 million), including an undisclosed upfront payment and contingent milestone payments.

Photo
21.11.2023 • News

Ineos and Sinopec Open New ABS Facility in China

Ineos Styrolution, a styrenics producer, has opened a new world-scale ABS (acrylonitrile butadiene styrene) facility located in Ningbo, China, together with its joint venture partner Sinopec. The facility has an annual nameplate capacity of 600,000 tons.

Photo
17.11.2023 • News

Brenntag Supports Energy Sector with New US Site in Louisiana

German chemicals and ingredients distributor Brenntag has opened its new facility in Maurice, Louisiana, USA. Strategically positioned along the US Gulf Coast, the new site will be the primary operations hub for Coastal Chemical, a subsidiary of Brenntag, in addition to serving other areas in the region, the company said.

Photo
17.11.2023 • News

AkzoNobel to Build Facility for Bisphenol-Free Coatings in Spain

AkzoNobel is investing €32 million in a new plant at its Vilafranca site in Spain, which will produce bisphenol-free coatings for the metal packaging industry in Europe, Middle East and Africa (EMEA). AkzoNobel expects facility to be operational by mid-2025 and to create around 40 jobs.

Photo
16.11.2023 • News

Harmonization of Carbon Accounting Methodologies

The $5 trillion chemical industry plays a pivotal role in the global economy, serving as the foundation for countless sectors from paints to plastics that rely on its products and processes. With a rich history of innovation, chemical companies are well-positioned to lead the charge on decarbonization.

Photo
16.11.2023 • News

Air Liquide and Eneos Partner on Low-Carbon Hydrogen in Japan

French industrial gases group Air Liquide and Japanese energy company Eneos have signed a memorandum of understanding (MoU) to collaborate on accelerating the development of low-carbon hydrogen in Japan and contribute to the energy transition, covering the entire low-carbon hydrogen value chain.

Photo
15.11.2023 • News

Merck to Relocate US Healthcare Headquarters to Boston

German chemicals, pharmaceuticals and life sciences group Merck, which operates its Healthcare business as EMD Serono in the US and Canada, announced that it plans to move its US Healthcare headquarters, currently located in Rockland, Massachusetts, to Boston’s Seaport district.

Photo
14.11.2023 • News

Evonik Launches ‘Circular Economy Program’

Evonik announced that it is significantly expanding its commitment to developing solutions for the circular economy, bundling its activities in the group-wide Circular Economy Program. From 2030, the German specialty chemicals company aims to generate at least €1 billion in additional sales per year from circular products and technologies.

Photo
13.11.2023 • News

Yara to Divest Fertilizer Business in Ivory Coast

Yara has decided to divest its fertilizer import and distribution subsidiary in Ivory Coast. The move follows a thorough analysis of the company’s operations, considering market dynamics, regulatory environment, and strategic growth opportunities.

12975 more News

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation